Diagnexia and Stratipath Partner to Expand AI-Based Cancer Precision Diagnostics Across the UK and Europe
Diagnexia, and Stratipath AB are pleased to announce a strategic partnership. This collaboration will bring Stratipath Breast, an AI-based prognostic risk profiling tool for invasive breast cancer, to pathology laboratories, hospitals, and healthcare providers across the UK and Europe.
Professor Daniel Hayes Joins Stratipath’s Scientific Advisory Board
Stratipath is proud to announce that globally recognized breast oncologist, Professor Daniel F. Hayes, has joined the company’s Scientific Advisory Board. Professor Hayes will collaborate closely with the board, chaired by Professor Jonas Bergh, to further advance Stratipath’s innovative solutions in breast cancer precision diagnostics.
Stratipath Secures Spot on Prestigious 33-List of Top Innovative Tech Companies for Third Consecutive Year
Stratipath has been recognized as one of the Gold Companies on NyTeknik – First with news about technology and IT. and Affärsvärlden’s prestigious 33-list – for the maximum three consecutive years!
Unilabs is implementing Stratipath Breast for enhanced breast cancer diagnostics at Capio S:t Göran’s Hospital
Capio St Göran’s Hospital is one of the largest breast cancer clinics in Sweden treating more than 600 breast cancer patients annually. With this new collaboration, Unilabs will use Stratipath Breast on a selected group of these patients.
Article in ”Oncology in Sweden” on the continuation of SwAIPP (Sweden AI Precision Pathology)
SwAIPP 2, the continuation of the SwAIPP project, has been funded by Sweden’s innovation agency, Vinnova. We at Stratipath are proud to be partners in this consortium alongside leaders in academia, healthcare, and industry.
Podcast: “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Article at Genomeweb: ”Stratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Test”
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
TV4 morning show: Report: New Drugs Are Not Reaching All Breast Cancer Patients
Advances in breast cancer research are providing entirely new opportunities to diagnose and treat the most common cancer among women. Today, the Breast Cancer Association is releasing a report on access to the advanced diagnostic methods needed to determine whether a patient will benefit from specific medications, known as precision diagnostics. Susanne Dieroff Hay, Chair of the Breast Cancer Association, and Johan Hartman, tumor pathologist at Karolinska University Hospital, share their insights.
Unilabs Sverige and St. Göran’s Hospital are soon adopting Stratipath Breast for breast cancer risk profiling.
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”
Article in Impact loop.
“We have the first product in this field approved for hospital use. But AI is advancing rapidly, so there will be competition, which is great. The market is large, so there’s room for more players.”